FY2020 Sales of 7 Major Japan Drug Makers Slip 2.7% on COVID-19, Price Woes: Tally

Combined sales of seven major Japanese drug makers in FY2020 skidded 2.7% over the previous year as their brisk global performance could not counter the blow from price cuts at home as well as the COVID-19 and foreign exchange impact,...read more